Soru

Zorluk: Çok zorGastroenterology and Hepatology

A 5858-year-old man with decompensated cirrhosis due to alcohol use disorder is evaluated on hospital day 33 for ongoing management of spontaneous bacterial peritonitis. He initially presented with a temperature of 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), diffuse abdominal pain, and confusion. Diagnostic paracentesis on admission showed an ascitic fluid absolute neutrophil count of 850/mm3850/\text{mm}^3. Because of a history of extended-spectrum beta-lactamase (ESBL)-producing *Escherichia coli* bacteriuria 66 months ago, he was empirically started on intravenous meropenem. Intravenous albumin (1.51.5 g/kg) was also administered on admission based on the following laboratory results:

Admission (Day 1):
Blood urea nitrogen: 3434 mg/dL
Serum creatinine: 1.51.5 mg/dL
Total bilirubin: 5.25.2 mg/dL

Today (Day 3), the patient is feeling much better. His temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), and his mental status has returned to baseline. Ascitic fluid cultures from admission have grown *Klebsiella pneumoniae*. Antimicrobial susceptibility testing is as follows:
Ampicillin: Resistant
Ceftriaxone: Susceptible
Ciprofloxacin: Susceptible
Meropenem: Susceptible
Piperacillin-tazobactam: Susceptible

Current laboratory results:
Blood urea nitrogen: 2424 mg/dL
Serum creatinine: 1.11.1 mg/dL
Total bilirubin: 4.54.5 mg/dL

Which of the following is the most appropriate next step in the management of this patient?

  1. A
    Continue intravenous meropenem and administer intravenous albumin
  2. B
    Continue intravenous meropenem and withhold intravenous albumin
  3. Switch to intravenous ceftriaxone and administer intravenous albuminCevap
  4. D
    Switch to intravenous ceftriaxone and withhold intravenous albumin
  5. E
    Switch to oral ciprofloxacin and withhold intravenous albumin

Cevap

Switch to intravenous ceftriaxone and administer intravenous albumin
The correct approach involves de-escalating antibiotic therapy to a narrower-spectrum agent and completing the protocol-driven albumin infusion. The ascitic fluid culture grew *Klebsiella pneumoniae* susceptible to ceftriaxone. While the initial choice of meropenem was justified by the patient's history of ESBL-producing bacteriuria and severe presentation, antimicrobial stewardship mandates de-escalation once sensitivities are available to prevent the development of multidrug-resistant organisms. Ceftriaxone provides targeted and highly effective coverage for this isolate. Furthermore, patients with spontaneous bacterial peritonitis (SBP) who meet high-risk criteria upon diagnosis (serum creatinine > 1.01.0 mg/dL, blood urea nitrogen > 3030 mg/dL, or total bilirubin > 4.04.0 mg/dL) require intravenous albumin to prevent hepatorenal syndrome. The proven regimen is 1.51.5 g/kg on Day 1 and 1.01.0 g/kg on Day 3. Because this patient met all three criteria initially, the Day 3 albumin dose must be administered to complete the prophylactic course and prevent clinical deterioration, despite the interim improvement in his renal indices.

Adım Adım Çözüm

1
Evaluate the antibiotic susceptibility results for the isolated pathogen.
The *Klebsiella pneumoniae* isolate is susceptible to ceftriaxone.
Determines if the empiric broad-spectrum antibiotic (meropenem) can be de-escalated to a narrower, targeted agent.
2
Apply principles of antimicrobial stewardship.
Therapy should be switched from intravenous meropenem to intravenous ceftriaxone.
Meropenem is an ultra-broad-spectrum carbapenem. De-escalation to ceftriaxone (a third-generation cephalosporin) provides effective treatment while minimizing the selection pressure for multidrug-resistant organisms.
3
Assess the indication for Day 3 albumin administration.
The patient must receive the Day 3 dose of intravenous albumin.
The patient met the high-risk criteria for hepatorenal syndrome on Day 1 (Cr > 1.0 mg/dL, BUN > 30 mg/dL). The standard prophylactic regimen requires albumin on Day 1 (1.51.5 g/kg) and Day 3 (1.01.0 g/kg). The Day 3 dose is mandatory to complete the protocol, even if renal indices have improved.

Anahtar Kavram

In patients with spontaneous bacterial peritonitis, empiric broad-spectrum antibiotics should be de-escalated based on culture susceptibilities, and those meeting high-risk criteria on admission must complete the full Day 1 and Day 3 intravenous albumin protocol to prevent hepatorenal syndrome.
Bu soruyu puanla